Condition: Esophageal Squamous Cell Carcinoma · Esophageal Cancer · Metastatic Esophageal Squamous Cell Carcinoma · Sponsor: Shanghai Chest Hospital
SCR-ESCC-01 is a multicenter, randomized, phase II study aiming to investigate the benefit of early involvement of low-dose radiotherapy(LDRT) and conventionally fractionated radiotherapy(CFRT) in the first-line anti-PD-1 based treatment of metastatic ESCC. It begins with a safety run-in phase, followed by a randomized controlled comparison against standard immunochemotherapy.
This description comes directly from the study's public registry record.
Wen Yu, M.D · 021-22200000-3203 · yuzhiwen0827@163.com
Always discuss trial participation with your own doctor first.
| Shanghai Ruijin Hospital | Shanghai, China | Recruiting |
| Shanghai Chest Hospital | Shanghai, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05978193